BVIKM - 48th symposium

48th symposium

PARENTERAL ANTIBIOTICS: FROM INTENSIVE TO HOME DOSING

State of the art on PK-PD of betalactams.
- What do we know on PK-PD of betalactams? [Françoise VAN BAMBEKE (UCL, Brussels)]
- Optimization of the dosing of beta-lactams to prevent emergence of resistance. [Vincent TAM (University of Houston, Houston, United States)]
- Increased dosing of betalactams = increased toxicity? [Marjorie Beumier (CHU Ambroise Paré, Mons)]
- Interactive questions on the clinical translation of recent PK-PD insights.
- Intermittent infusion without TDM. [Deborah KONOPNICKI (UMC Sint-Pieter - CHU Saint-Pierre, Brussels)]
- Intermittent infusion with TDM. [Patrick HONORE (UZ Brussel, Brussels)]
- Prolonged infusion with TDM. [Maya HITES (Hôpital Erasme -ULB, Brussels)]
- Prolonged infusion without TDM. [Jan DE WAELE (UZ Gent, Ghent)]
OPAT (outpatient parenteral antibiotic therapy).
- OPAT: what is in a name? [Franky BUYLE (UZ Gent, Ghent)]
- Possible indictions for OPAT. [Xavier HOLEMANS (Grand Hôpital de Charleroi, Charleroi]
- OPAT: which antibiotics can be used? [Franky BUYLE (UZ Gent, Ghent)]
- Organisation of OPAT: international literature put into practice in Belgium. [Ester STEFFENS (UZ Leuven, Leuven)]
- OPAT: a pilot project. [Dirk VOGELAERS (UZ Gent, Ghent)]